Literature DB >> 22951055

Specificity and responsiveness of patient-reported and clinician-rated outcome measures in the context of elbow surgery, comparing patients with and without rheumatoid arthritis.

J Dawson1, H Doll, I Boller, R Fitzpatrick, C Little, J Rees, A Carr.   

Abstract

OBJECTIVES: To examine and contrast the ability of patient-reported and clinician-rated measures, reflecting different levels of specificity, to detect differences in outcomes between patients with and without rheumatoid arthritis (RA), at 6 months following elbow surgery.
METHODS: One hundred and four consecutive patients/elbows self-completed the Oxford Elbow Score (OES), Disabilities of the Arm, Shoulder and Hand (DASH) and SF-36 general health questionnaires prior to elbow surgery. A surgeon assessed the standard Mayo Elbow Performance Score (MEPS) and recorded patients' diagnoses. Assessments were repeated 6 months following surgery in an outpatient clinic. Patients also completed pain "transition" and global satisfaction items. Patients who did not attend completed their assessment by post.
RESULTS: Twenty-three (22%) patients had RA. These patients were more likely than other patients to have bilateral elbow problems and to have total elbow replacement (85.7% versus 10.5% P<0.001). Patients with RA had more severe preoperative elbow-specific scores, and experienced a large and significantly greater amount of change in elbow function, as measured by the OES function (P=0.002) and pain scales (P=0.013). The surgeon-assessed elbow-specific MEPS score also detected a large and significant difference between the two groups (P<0.001). However, these differences were not detected by the upper limb specific DASH, by any SF-36 general health dimensions, or by transition or satisfaction items.
CONCLUSIONS: The OES performed well in assessing surgical outcomes in patients with RA. Neither the upper limb specific DASH nor the SF-36 is specific or responsive enough to warrant its exclusive use as an outcome measure for elbow surgery. LEVEL OF EVIDENCE: Level II (prospective non-randomised study).
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22951055     DOI: 10.1016/j.otsr.2012.05.011

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  5 in total

Review 1.  Use of scoring systems for assessing and reporting the outcome results from shoulder surgery and arthroplasty.

Authors:  Simon Booker; Nawaf Alfahad; Martin Scott; Ben Gooding; W Angus Wallace
Journal:  World J Orthop       Date:  2015-03-18

2.  Psychometric properties of the Mayo Elbow Performance Score.

Authors:  Derya Celik
Journal:  Rheumatol Int       Date:  2014-12-31       Impact factor: 2.631

3.  A randomized clinical trial on comparison of corticosteroid injection with or without splinting versus saline injection with or without splinting in patients with lateral epicondylitis.

Authors:  Mohammad Ali Tahririan; Amir Moayednia; Amir Momeni; Arash Yousefi; Babak Vahdatpour
Journal:  J Res Med Sci       Date:  2014-09       Impact factor: 1.852

4.  Minimal important change and other measurement properties of the Oxford Elbow Score and the Quick Disabilities of the Arm, Shoulder, and Hand in patients with a simple elbow dislocation; validation study alongside the multicenter FuncSiE trial.

Authors:  Gijs I T Iordens; Dennis Den Hartog; Wim E Tuinebreijer; Denise Eygendaal; Niels W L Schep; Michael H J Verhofstad; Esther M M Van Lieshout
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

5.  PrEvention of posttraumatic contractuRes with Ketotifen 2 (PERK 2) - protocol for a multicenter randomized clinical trial.

Authors:  Ayoola Ademola; Kevin A Hildebrand; Prism S Schneider; Nicholas G H Mohtadi; Neil J White; Michael J Bosse; Alexandra Garven; Richard E A Walker; Tolulope T Sajobi
Journal:  BMC Musculoskelet Disord       Date:  2020-02-24       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.